Nkarta Therapeutics (United States)

Chemokine (C‐C motif) receptor 2–positive monocytes aggravate the early phase of acetaminophen‐induced acute liver injury

Jana C. Mossanen, Oliver Krenkel, Can Ergen et al. · Hepatology · 2016 · 316 citations · Full text

Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis

Éric Lefebvre, Graeme Moyle, Ran Reshef et al. · PLoS ONE · 2016 · 306 citations · Full text

Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design

Scott L. Friedman, Arun J. Sanyal, Zachary Goodman et al. · Contemporary Clinical Trials · 2016 · 196 citations · Full text

A Wnt-Responsive PDL Population Effectuates Extraction Socket Healing

Xue Yuan, Xibo Pei, Yuan Zhao et al. · Journal of Dental Research · 2018 · 92 citations

Tissue Engineering, Engineering, Bone Repair +16

Pharmacokinetics, Safety, and CCR2/CCR5 Antagonist Activity of Cenicriviroc in Participants With Mild or Moderate Hepatic Impairment

Éric Lefebvre, Mildred D. Gottwald, Kenneth C. Lasseter et al. · Clinical and Translational Science · 2016 · 51 citations · Full text